Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Trends in asbestos body counts in bronchoalveolar lavage fluid over two decades

P. Dumortier, J. Thimpont, V. de Maertelaer, P. De Vuyst
European Respiratory Journal 2003 22: 519-524; DOI: 10.1183/09031936.03.00001903
P. Dumortier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Thimpont
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. de Maertelaer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. De Vuyst
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

As in most western countries, the use of asbestos has decreased in Belgium since the mid 1970's. Successive regulations have lowered the permissible levels of exposure and prohibited the use of various asbestos products.

In order to assess the impact of these prevention measures on the pulmonary fibre burden of asbestos-exposed patients, the bronchoalveolar lavage fluid (BALF) asbestos body (AB) analysis database of the authors' laboratory was reviewed for the period 1983–2000.

A total of 4,772 cases were considered, of which 95% were males. AB concentration exceeded 1 AB·mL BALF−1 in 36.1%. There was essentially no change in the mean concentration of AB over the period evaluated. However, the concentrations in individuals with very high levels decreased over time. This was associated with a shift in exposure categories from primary asbestos workers to those exposed during handling of asbestos-containing materials or to asbestos in place in buildings or industrial sites.

This is consistent with epidemiological data indicating that the number of severe cases of asbestosis caused by very high cumulated doses decreases but that benign pleural diseases and mesothelioma remain the most frequent asbestos-related diseases. Past prevention measures are not expected to have a measurable influence on the incidence of mesothelioma in the near future.

  • asbestos body
  • bronchoalveolar lavage
  • mesothelioma
  • trend

Restrictive regulations for occupational asbestos exposure levels and prohibitions concerning the use of certain types of products were gradually implemented in parallel with the accumulation of evidence about the adverse effects of asbestos on health. The utilisation of asbestos has declined since the mid 1970's and its use is now banned or strictly controlled in many Western countries 1, 2.

In Belgium, a total of ∼2×106 tons of asbestos has been imported since 1948. It can be deduced from the geographical origin of imported asbestos that amphiboles accounted for 5–10% of the Belgian imports. In 1978, asbestos spraying, asbestos insulation and raw asbestos handling were banned. The threshold limit values (TLV)s for occupational asbestos exposures were set at 0.2 f·mL−1 for crocidolite and to 2 f·mL−1 for all other types of asbestos. In 1986, these values were reduced to 0.15 and 1 f·mL−1, respectively. In 1991, the TLVs were set to 0.15 f·mL−1 for all amphiboles and 0.5 f·mL−1 for chrysotile. The use of asbestos was banned in 1998, except for a few specific applications allowed until 1st January 2002.

Exposure to asbestos-containing materials (ACM)s in buildings or in industrial sites is still a concern for many trades. Progressive degradation due to aging of these materials or to maintenance work may release airborne fibres and constitute a potential hazard for several occupational groups, such as construction and maintenance workers, electricians, and steel or refinery workers 1, 3–6.

Counting asbestos bodies (AB)s in bronchoalveolar lavage fluid (BALF) by light microscopy can be used to help evaluate an individual's past exposure to asbestos 7. ABs mainly reflect exposure to amphibole asbestos. Concentrations >1 AB·mL BALF−1 usually indicate an asbestos exposure exceeding that of the general population 8.

BALF samples have been sent to the current authors' laboratory by chest physicians throughout Belgium since 1980 and a systematic database has been maintained since 1983. The aim of this study was to analyse whether past reductions in the use of asbestos and in exposure levels in Belgium would be reflected as changes in the BALF AB counts over the period 1983–2000.

Materials and methods

Samples analysed between 1 January 1983 and 31 December 2000 were identified from the database. The following exclusions were made: 1) where several samples are available for the same patient, only the result of the first suitable sample was included; 2) samples from Turkish immigrants with possible environmental exposures to tremolite or erionite in Turkey 9 were excluded; 3) samples with <5 mL of BALF (n=40) were excluded because such a small volume is probably associated with sampling problems; and 4) all cases where sampling problems were mentioned were excluded. Information on sex and age were available for most patients, but details concerning BALF quality, cells counts, occupational exposure and disease were often incomplete or missing. For the subgroup of patients with counts above the annual 95th percentile, additional information about occupation and disease was collected from the files of the Belgian Occupational Diseases Fund.

The study period was divided into two equal subperiods to examine possible shifts in the proportions of positive cases among the whole population and of occupations or diseases among those with counts above the annual 95th percentiles.

Assuming that the majority of the cases had started their main occupation around the age of 20 yrs, the date of entrance into working life was estimated according to the following algorithm: Embedded ImageNa hypochlorite digestion and filtration on membrane filters (Millipore Corporation, Bedford, MA, USA) were used to collect the ABs from BALF. Counting was performed by phase contrast light microscopy 8. The analytical sensitivity was ∼0.1 AB·mL BALF−1. The mean volume of BALF analysed was 26±15 mL (range 5–195). An analytical transmission electron microscope fitted with an energy dispersive x‐ray analyser was used to determine the nature of the core fibre of ABs in some cases.

Statistical analysis

Ages and durations of exposure were compared using the unpaired t‐test. The Chi-squared test was used to look for a possible relationship between categories of age, AB threshold, or occupation and the sampling period. Mean concentrations are reported as geometric mean (GM), geometric standard deviation and 95% confidence interval of the GM. Linear regression analysis was used to assess the trend of AB concentrations over time. A value of half the analytical sensitivity of the method (0.05 AB·m−1) was attributed to null counts in order to enable graphical presentation of concentrations on a logarithmic scale and calculation of regression lines.

Results

There were 4,772 eligible samples between 1983–2000. Annual numbers of samples ranged 220–329. The mean age of the patients was 58 yrs (range 17–92) and 95% of the patients were male. There was no marked change in the sex ratio between 1983–2000, while the mean age of the patients increased by 6 yrs over the study period (table 1⇓). AB concentrations ranged from <0.1 to 4,661 AB·mL−1. They exceeded 1 AB·mL−1 in 1,723 (36.1%) samples and 5 AB·mL−1 in 848 (17.8%). There were no ABs in 1,689 (35.4%) of the BALF samples. The fraction of samples without ABs did not change over the study period (table 1⇓). They accounted for 34% of the samples in males and 57% in females.

View this table:
  • View inline
  • View popup
Table 1

Number of cases examined between 1983–2000, mean age, sex ratio and percentages of samples without asbestos bodies (AB)s and with AB counts >1 and 5 AB·mL−1 bronchoalveolar lavage fluid (BALF) thresholds

The proportion of samples with ≥1 AB·mL−1 decreased significantly from 1983–1991 to 1992–2000 among those aged <50 yrs, but did not change among those aged >50 yrs (table 2⇓).

View this table:
  • View inline
  • View popup
Table 2

Number of cases with asbestos body (AB) counts < and >1 AB·mL bronchoalveolar lavage fluid−1 in 1983–1991 and 1992–2000 according to age

Figure 1⇓ shows a very small, but significant, decrease of the mean concentrations over years, with a linear regression analysis equation as follows: Embedded Image(pslope and pintercept <0.005, R2=0.0016). However, this trend becomes nonsignificant if the 36 patients with the highest counts are excluded. The lowest count in this subgroup was 390 AB·mL−1.

Fig. 1.—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.—

Scatterplot of asbestos body (AB) concentrations in bronchoalveolar lavage fluid (BALF) according to the year of sampling. The equation of the regression line is log[AB]=16.542−0.00846×year (––). Levels of 390 and 30 AB·mL BALF−1 are also indicated (‐‐‐‐) (see Results and Discussion sections). ND: not detected.

A linear regression model was also used to assess the trend for the patients with concentrations above the respective annual 95th percentiles (n=246), as a further quadratic term was not statistically significant (p=0.079). The linear regression equation was as follows: Embedded Image(pslope and pintercept <0.001) (fig. 2⇓). The type and duration of occupational exposure were known for 222 (90%) and 202 (82%), respectively, of these 246 patients (table 3⇓). Time elapsed since end of exposure was rarely available. Patients sampled in 1983–1991 were slightly younger than those sampled in 1992–2000 ((mean±sd) 57±11 versus 61±11 yrs; p=0.0016) but the duration of exposure did not differ (21±10 versus 23±12 yrs; p=0.17). Occupations were categorised into three groups according to the type of asbestos exposure asfollows: 1) group I: those engaged in handling of raw asbestos, in installation of asbestos insulation or in production of ACMs; 2) group II: those whose occupational titles suggest contact to asbestos in place or use of ACMs; and 3) group III: the remaining occupations with either rare or less homogeneous asbestos exposure. Details about the types of occupations included in each of the groups are given in the footnote of table 3⇓. Figure 3⇓ shows that the proportion of patients in group I was significantly higher in 1983–1991 than in 1992–2000, while the proportion of patients in group II was higher in 1992–2000 (p<0.0001). The Occupational Disease Fund had files for 170 of the 246 patients (69%) and 146 had been recognised as having an asbestos-related disease. Seventy per cent of them had malignant mesothelioma or benign pleural diseases (table 3⇓). Three patients with lung cancer during 1983–1991 also had asbestosis. All cases of asbestosis between 1983 and 1991 (n=7) had been attributed a degree of disability >40% compared to only one of eight between 1992 and 2000. This suggests that the more recent cases of lung fibrosis were less severe. Moreover, the diagnosis of asbestosis is essentially based on computed tomography scans since 1990, also contributing to the recognition of less severe cases. All the cases with asbestosis had AB counts >100 in 1983–1991, versus only three out of eight in 1992–2000.

Fig. 2.—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.—

Detailed scatterplot of asbestos body (AB) concentrations in bronchoalveolar lavage fluid (BALF) exceeding the annual 95th percentile according to the year of sampling. The equation of the regression line is log[AB]=93.526−0.046×year (–––).

Fig. 3.—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.—

Distribution of occupations in the cases with asbestos body counts above the annual 95th percentile during the periods 1983–1991 (└; n=103) and 1992–2000 (□; n=119) (see Results section and table 3⇓ for definition of the groups). prod.: production; hand.: handling; demo.: demolition.

View this table:
  • View inline
  • View popup
Table 3

Distribution of type of exposure and disease among cases with asbestos body counts in bronchoalveolar lavage fluid above the annual 95th percentile in 1983–1991 and 1992–2000 in Belgium

All patients with counts >1,000 AB·mL BALF−1 (n=15) entered working life before 1968, all those in the range 100–999 AB·mL−1 (n=105) before 1972 and all those in the range 50–99 AB·mL−1 (n=76) before 1980. Table 4⇓ shows that the proportion of cases with >1 AB·mL−1 is significantly lower among those who entered working life after 1978, the year when the first asbestos regulations were applied in Belgium. However, these cases were significantly younger than those inthe same age range (<50 yrs) who entered working life before 1978 (mean age 32.3±5.4 versus 43.5±5.0; p<0.001). Nine cases (5%) who had begun to work after 1978 had >10 AB·mL BALF−1. Analytical transmission electron microscopy showed that the core fibre of the “typical” AB was only amosite or crocidolite in four cases, only chrysotile in three and mostly refractory ceramic fibres in two cases.

View this table:
  • View inline
  • View popup
Table 4

Distribution of bronchoalveolar lavage fluid (BALF) asbestos body (AB) concentration according to year of entry into working life and age

Discussion

The effect of the reduction of occupational exposure levels and asbestos consumption in Belgium since the mid 1970's on the pulmonary AB burden of the patients exposed to asbestos more than two decades later is very limited and some high exposures were still observed among the youngest age groups.

Most studies concerned with asbestos fibres or bodies in the human lungs have compared their concentrations with exposure characteristics and/or associated diseases in specific groups 10–15. The changes in the use of asbestos have only been taken into account exceptionally in the interpretation of mineralogical findings 16. Therefore, in this study, the evolution of a biomarker of asbestos exposure over a relevant period of time in a very large number of workers was examined.

Although the material is restricted to those individuals for whom a BAL was performed, i.e. individuals with some suspicion of an asbestos exposure or asbestos-related disease, the probability that any other selection process could have biased the results is low. For example, the samples were collected from referring chest departments with a wide geographical distribution all over Belgium, there was a wide variety of occupations and diseases, and the annual number of cases and the sex ratio were quite stable over the years. Furthermore, all the analyses had been made in the same laboratory with the same technique. In some instances, the BAL procedure may result in samples of poor quality 8, e.g. in cases with severe chronic obstructive pulmonary disease, but there is no evidence that the proportion of unsuitable samples has changed markedly over time. It is not possible to control whether clinicians become more confident in their diagnoses and send less samples of the more obvious cases, however, the statistics of the Occupational Diseases Fund confirm a decrease in the percentage of disability attributed to cases of asbestosis.

The main determinants of the AB burden in the lungs are related to exposure, to fibre type and individual factors. Intensity, duration and pattern of individual exposure may have varied widely over time, especially in jobs where preventive protection measures were implemented 17. Type and size distribution of the fibres deposited in the lungs affect AB formation. ABs are mainly formed on amphibole asbestos fibres >10 µm in length 18, 19, whose clearance from the lung is low. They can be detected in BALF even >40 yrs after the end of exposure 20. Although ABs on chrysotile have been reported in some specific occupations 21, the biopersistance of chrysotile fibres in the lungs is much shorter than that of amphibole fibres 22 and the relevance of mineralogical analyses in assessing past exposures to chrysotile is questionable 16, 23. According to the present authors' experience with repeated BALFs in several cases exposed to chrysotile, the biopersistence of ABs on chrysotile in BALF appears to be <10 yrs (unpublished results). However, observations on ABs, mainly built on amphibole fibres, appear relevant since a recent meta-analysis of mesothelioma and lung cancer mortality reports exposure-specific risks for amosite and crocidolite one-to-two orders of magnitude higher than for chrysotile 24.

The decline of asbestos use and the introduction of increasingly stringent regulations had only a very limited impact on the ABs concentrations in BALF between 1983–2000. The decrease observed over the years appears to be mainly due to the disappearance of cases with a very high AB count. Consistently, this trend would be more apparent if a series of 104 cases examined in 1980–1981, which were included in an earlier study, were taken into account 25. These were not included in this study, as there is a high likelihood of a selection bias during this initial period, with focus on prevalent cases of primary asbestos workers with asbestosis. These cases are nevertheless interesting in confirming the observed trends. The highest AB concentrations in BALF ever measured in the laboratory were observed among these patients. Three cases had counts >5,000 AB·mL−1 during this period, while none have been recorded since 1983.

The constancy in the proportion of cases with >1 AB·mL−1 between 1983–2000 indicates that such cases will still be detected in the future. Interestingly, there were fewer cases among those aged <50 yrs examined after 1991 and among those presumed to have entered working life after 1978. This is an indication that subjects from the youngest and most recently exposed group were exposed to lower cumulative doses or to less biopersistent chrysotile fibres.

Analysis of the AB's core fibre type by electron microscopy in the nine cases who entered working life after 1978 and had >10 AB·mL−1 also provide information on the recent exposure characteristics. First, the disclosure of ABs on chrysotile or pseudo‐ABs on ceramic fibres in five of these cases reflects recent exposure to less biopersistent fibres that did not have sufficient time to be cleared and the use of asbestos substitutes in some applications, respectively. Secondly, one of the cases with ABs on amphiboles had been environmentally exposed in the 1960's by playing on the dumps of an asbestos cement factory as a child. Thirdly, the three remaining cases (one welder, one heating mechanic and one sand blaster of metallic parts) indicate that uncontrolled exposure conditions may still have occurred after 1978.

Concerning the occupations of the subgroup with high AB burdens in BALF, there was a shift from “primary asbestos workers” to those exposed during handling of ACMs or to asbestos in place in buildings or industrial sites. Most of the recent cases with high AB counts had been exposed in construction and building-related activities, metal production and welding, or in power plants. Control of such exposures has certainly been more limited and much less efficient compared to the situation in the ACM production industry. These occupational groups account for an important fraction of the current mesothelioma cases 1, 26, 27. Mineralogical analysis of lung tissue showed that amosite and crocidolite fibres could account for 80–90% of the mesothelioma cases in those aged <50 yrs old in such occupations 16.

The observations reported here support the epidemiological inferences concerning the evolution of the spectrum of asbestos-related diseases in Western countries. As a result of the implementation of exposure-control measures in the 1970's, asbestosis is currently considered a disappearing disease, especially in its severe forms 28. It has been estimated that clinical or radiological asbestosis is caused by cumulated exposures of ≥25 fibres·mL−1·yr−1 29, 30. This dose is estimated to be roughly equivalent to 5–15 AB·mL BALF−1 31. In this series 8, 90% of asbestosis cases had ≥5 AB·mL−1 and 75% had ≥30 AB·mL−1. In contrast, 66% of cases with pleural plaques and 70% of mesothelioma cases had <30 AB·mL BALF−1. The lack of a clear decreasing trend in the proportion of BALF with AB counts in this range between 1983–2000 indirectly confirms the epidemiological expectations that the incidence of mesothelioma will remain high in the near future 32. Although most of the individuals with ABs in BALF will not develop asbestos-related malignancies, a large number of subjects are at risk and this will probably decrease only very slowly.

Conclusions

Control measures of occupational exposure levels and of asbestos consumption in Belgium have been efficient in reducing exposures resulting in very high AB counts, thereby preventing cases of asbestosis. A decrease in incidence is not yet expected for mesothelioma or benign pleural diseases. Due to an increase in life expectancy, more and more of these subjects will reach latencies compatible with the development of mesothelioma.

Stricter application of the existing regulations and better information for the workers still potentially at risk of exposure to asbestos in place is needed.

Acknowledgments

The authors would like to thank J.M. Caroyer, who allowed the use of patient data from the Occupational Diseases Fund, and M. Vandecauter from the Statistical Department of the Belgian Office for Foreign Trade, who provided statistics about asbestos imports in Belgium.

  • Received January 8, 2003.
  • Accepted May 14, 2003.
  • © ERS Journals Ltd

References

  1. ↵
    Peto J, Hodgson JT, Matthews FE, Jones JR. Continuing increase in mesothelioma mortality in Britain. Lancet 1995;345:535–539.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    Goldberg M, Banaei A, Goldberg S, Auvert B, Luce D, Gueguen A. Past occupational exposure to asbestos among men in France. Scand J Work Environ Health 2000;26:52–61.
    OpenUrlPubMedWeb of Science
  3. ↵
    Gennaro V, Finkelstein MM, Ceppi M, et al. Mesothelioma and lung tumors attributable to asbestos among petroleum workers. Am J Ind Med 2000;37:275–282.
    OpenUrlCrossRefPubMedWeb of Science
  4. Hodgson MJ, Parkinson DK, Sabo S, Owens GR, Feist JH. Asbestosis among electricians. J Occup Med 1988;30:638–640.
    OpenUrlCrossRefPubMedWeb of Science
  5. Corhay JL, Delavignette JP, Bury T, Saint-Remy P, Radermecker MF. Occult exposure to asbestos in steel workers revealed by bronchoalveolar lavage. Arch Environ Health 1990;45:278–282.
    OpenUrlPubMedWeb of Science
  6. ↵
    Anderson HA, Hanrahan LP, Higgins DN, Sarow PG. A radiographic survey of public school building maintenance and custodial employees. Environ Res 1992;59:159–166.
    OpenUrlPubMed
  7. ↵
    De Vuyst P, Karjalainen A, Dumortier P, et al. Guidelines for mineral fibre analyses in biological samples: report of the ERS Working Group. European Respiratory Society. Eur Respir J 1998;11:1416–1426.
    OpenUrlAbstract
  8. ↵
    De Vuyst P, Dumortier P, Moulin E, Yourassowsky N, Yernault J. Diagnostic value of asbestos bodies in bronchoalveolar lavage fluid. Am Rev Respir Dis 1987;136:1219–1224.
    OpenUrlPubMedWeb of Science
  9. ↵
    Dumortier P, Gocmen A, Laurent K, Manco A, De Vuyst P. The role of environmental and occupational exposures in Turkish immigrants with fibre-related disease. Eur Respir J 2001;17:922–927.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Pairon JC, Martinon L, Iwatsubo Y, et al. Retention of asbestos bodies in the lungs of welders. Am J Ind Med 1994;25:793–804.
    OpenUrlCrossRefPubMedWeb of Science
  11. Pairon JC, Orlowski E, Iwatsubo Y, et al. Pleural mesothelioma and exposure to asbestos: evaluation from work histories and analysis of asbestos bodies in bronchoalveolar lavage fluid or lung tissue in 131 patients. Occup Environ Med 1994;51:244–249.
    OpenUrlAbstract/FREE Full Text
  12. Orlowski E, Pairon JC, Ameille J, et al. Pleural plaques, asbestos exposure, and asbestos bodies in bronchoalveolar lavage fluid. Am J Ind Med 1994;26:349–358.
    OpenUrlPubMedWeb of Science
  13. Tuomi T, Oksa P, Anttila S, et al. Fibres and asbestos bodies in bronchoalveolar lavage fluids of asbestos sprayers. Br J Ind Med 1992;49:480–485.
    OpenUrlPubMedWeb of Science
  14. Wagner JC, Moncrieff CB, Coles R, Griffiths DM, Munday DE. Correlation between fibre content of the lungs and disease in naval dockyard workers. Br J Ind Med 1986;43:391–395.
    OpenUrlPubMedWeb of Science
  15. ↵
    Churg A, Vedal S. Fiber burden and patterns of asbestos-related disease in workers with heavy mixed amosite and chrysotile exposure. Am J Respir Crit Care Med 1994;150:663–669.
    OpenUrlPubMedWeb of Science
  16. ↵
    McDonald JC, Armstrong BG, Edwards CW, et al. Case-referent survey of young adults with mesothelioma: I. lung fibre analyses. Ann Occup Hyg 2001;45:513–518.
    OpenUrl
  17. ↵
    Van Cleemput J, De Raeve H, Verschakelen JA, Rombouts J, Lacquet LM, Nemery B. Surface of localized pleural plaques quantitated by computed tomography scanning: no relation with cumulative asbestos exposure and no effect on lung function. Am J Respir Crit Care Med 2001;163:705–710.
    OpenUrlPubMedWeb of Science
  18. ↵
    Churg A, Warnock ML, Green N. Analysis of the cores of ferruginous (asbestos) bodies from the general population. II. True asbestos bodies and pseudoasbestos bodies. Lab Invest 1979;40:31–38.
    OpenUrlPubMedWeb of Science
  19. ↵
    Morgan A, Holmes A. The enigmatic asbestos body: its formation and significance in asbestos related disease. Environ Res 1985;38:283–292.
    OpenUrlPubMed
  20. ↵
    De Vuyst P, Dumortier P, Gevenois PA. Analysis of asbestos bodies in BAL from subjects with particular exposures. Am J Ind Med 1997;31:699–704.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    Dumortier P, De Vuyst P, Strauss P, Yernault J. Asbestos bodies in bronchoalveolar lavage fluids of brake lining and asbestos cement workers. Br J Ind Med 1990;47:91–98.
    OpenUrlPubMedWeb of Science
  22. ↵
    Churg A. Deposition and clearance of chrysotile asbestos. Ann Occup Hyg 1994; 38 625–633:424–425.
  23. ↵
    Rees D, Phillips JI, Garton E, Pooley FD. Asbestos lung fibre concentrations in South African chrysotile mine workers. Ann Occup Hyg 2001;45:473–477.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 2000;44:565–601.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    De Vuyst P, Jedwab J, Dumortier P, Vandermoten G, Vande Weyer R, Yernault JC. Asbestos bodies in bronchoalveolar lavage. Am Rev Respir Dis 1982;126:972–976.
    OpenUrlPubMedWeb of Science
  26. ↵
    McDonald JC, Edwards CW, Gibbs AR, et al. Case-referent survey of young adults with mesothelioma: II. occupational analyses. Ann Occup Hyg 2001;45:519–523.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Neumann V, Günther S, Müller KM, Fischer M. Malignant mesothelioma - German mesothelioma register 1987–1999. Int Arch Occup Environ Health 2001;74:383–395.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    Becklake MR.. The epidemiology of asbestosisIn: Liddell D, Miller K, editors. Mineral Fibers and HealthFlorida, CRC Press, 1991; pp. 103–119.
  29. ↵
    Doll R, Peto J. Effects in health of exposure to asbestosHealth and Safety Commission. London, Her Majesty's Stationery Office, 1985.
  30. ↵
    Ontario Royal Commission. On matters of health and safety arising from the use of asbestos in OntarioToronto, Ontario Ministry of the Attorney General, 1984.
  31. ↵
    Henderson DW, Leigh J. Asbestos and lung cancer: a selective up-date to the Helsinki Criteria for indiviual attributionIn: Tossavainen A, Lethinen S, Huuskonen M, Ratanen J, editors. New Advances in Radiology and Screening of Asbestos-Related Diseases. People and Work. Research report 36Helsinki, Finish Institute of Occupational Health, 2000; pp. 3–18.
  32. ↵
    Peto J, Decarli A, LaVecchia C, Levis F, Negri E. The European mesothelioma epidemic. Br J Cancer 1999;79:666–672.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
View this article with LENS
Vol 22 Issue 3 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Trends in asbestos body counts in bronchoalveolar lavage fluid over two decades
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Trends in asbestos body counts in bronchoalveolar lavage fluid over two decades
P. Dumortier, J. Thimpont, V. de Maertelaer, P. De Vuyst
European Respiratory Journal Sep 2003, 22 (3) 519-524; DOI: 10.1183/09031936.03.00001903

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Trends in asbestos body counts in bronchoalveolar lavage fluid over two decades
P. Dumortier, J. Thimpont, V. de Maertelaer, P. De Vuyst
European Respiratory Journal Sep 2003, 22 (3) 519-524; DOI: 10.1183/09031936.03.00001903
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Materials and methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Respiratory symptoms in children and exposure to pesticides
  • Incidence of probable occupational asthma and changes in airway calibre and responsiveness in apprentice welders
Show more Original Articles: Environmnetal and Occupational Exposures

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society